4528 — ONO PHARMACEUTICAL Share News
0.000.00%
Last trade - 00:00Brief: Schrödinger Gets Milestone Payment From Ono
Brief: Forty Seven & Ono Pharmaceutical Co Sign Regional License Agreement
To Buy Back Up To 2.92% Of Own Shares Worth 30 Billion Yen And Cancel Them On Oct. 31
Table: Ono Pharm -2018/19 group results (IFRS)
Brief: Vect-Horus Enters Into Collaboration And License Agreement With Ono Pharmaceutical Co Ltd
As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices
Table: Ono Pharm -9-MTH group results (IFRS)
Table: Ono Pharm -6-MTH group results (IFRS)
Japan's Ono Pharma hits over 1-mth low after cancer drug Opdivo fails trial study
Reuters Insider - Asia Insight: Indonesia's search for survivors
Ono Pharma shares soar; Nobel awarded for cancer-fighting method used in its drug
Brief: Ono Pharmaceutical says collaboration with Fate Therapeutics for two iPSC-derived CAR-T Therapies for Cancers
Table: Ono Pharm -Q1 group results (IFRS)
Table: Ono Pharm -2017/18 group results (IFRS)
Japan's Ono Pharma dives after Merck's Keytruda leads in lung cancer
Japan's Ono Pharma slumps as Merck drug succeeds lung cancer trial
Japan's Ono Pharmaceutical rises after report of plan to expand use of cancer drug
Table: Ono Pharm -9-MTH group results (IFRS)
Brief: Ono Pharmaceutical enters into license agreement with Bristol-Myers Squibb for Prostaglandin E2 receptor antagonists